Aug. 21, 2024 — An international team of scientists has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth. AML cells prevent the synthesis of proteins that ...

Announced Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) with Next and Final Analysis Planned Upon Reaching 80 Events ...

Among responders, one achieved complete response (CR), while three had partial response (PR) with target lesion shrinkages ... for pediatric AML; and for SLS009, RPDD for pediatric AML, pediatric ...

Among responders, one achieved complete response (CR), while three had partial response (PR) with target lesion ... AML; and for SLS009, RPDD for pediatric AML, pediatric acute lymphoblastic ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, ...

An abdominal computed tomography (CT) scan performed 1 month back in a nearby hospital had revealed an abnormal density lesion in the S6/7 segments of the liver. Leukemia recurrence was suspected due ...

this is the youngest woman presenting a large renal lesion concurrent with pulmonary and brain metastases. Disease remission had been achieved by treatment with combined chemotherapy and whole brain ...

Fanconi anemia can increase the risk of acute myeloid leukemia (AML). Tumors also can develop in the ... An occult (hidden or unrecognized) breast cancer happens when there is no primary lesion in the ...

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive ...